Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.46 is 14% below its 5-year average of 0.54, near the low end of its 5-year range (0.24–1.01).
As of the fiscal period ended Tuesday, June 30, 2026. 38.75% above its 12-month average of 0.33.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.46.
QUICK RATIO (ACID-TEST)
0.46
QUICK RATIO (ACID-TEST) AVG TTM
0.33
QUICK RATIO (ACID-TEST) AVG 3Y
0.47
QUICK RATIO (ACID-TEST) AVG 5Y
0.54
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+38.75%
CURRENT VS 3Y AVG
-1.52%
CURRENT VS 5Y AVG
-14.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-86.22%
vs the sector median at left
P3 Health Partners Inc.
Market Cap
$18.80M
Quick Ratio (Acid-Test)
0.46
TTM Avg
0.33
3Y Avg
0.47
5Y Avg
0.54
Market Cap
$18.81M
Quick Ratio (Acid-Test)
27.85
TTM Avg
15.71
3Y Avg
9.25
5Y Avg
10.43
Market Cap
$19.14M
Quick Ratio (Acid-Test)
1.25
TTM Avg
1.72
3Y Avg
2.15
5Y Avg
2.15
Market Cap
$17.99M
Quick Ratio (Acid-Test)
0.20
TTM Avg
0.34
3Y Avg
6.34
5Y Avg
6.11
Market Cap
$17.57M
Quick Ratio (Acid-Test)
0.92
TTM Avg
0.83
3Y Avg
1.35
5Y Avg
1.29
Market Cap
$20.16M
Quick Ratio (Acid-Test)
3.47
TTM Avg
5.82
3Y Avg
11.52
5Y Avg
18.07
Market Cap
$17.07M
Quick Ratio (Acid-Test)
11.48
TTM Avg
10.71
3Y Avg
12.62
5Y Avg
10.43
Market Cap
$16.77M
Quick Ratio (Acid-Test)
6.03
TTM Avg
7.38
3Y Avg
5.70
5Y Avg
5.02
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| P3 Health Partners Inc. (PIII) | $18.80M | 0.46 | 0.33 | 0.47 | 0.54 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.81M | 27.85 | 15.71 | 9.25 | 10.43 |
| Actuate Therapeutics Inc (ACTU)vs › | $19.14M | 1.25 | 1.72 | 2.15 | 2.15 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | 0.20 | 0.34 | 6.34 | 6.11 |
| PAVmed Inc. (PAVM)vs › | $17.74M | 1.19 | 0.11 | 0.43 | 2.24 |
| Cosmos Health Inc. (COSM)vs › | $17.57M | 0.92 | 0.83 | 1.35 | 1.29 |
| NextCure, Inc. (NXTC)vs › | $20.16M | 3.47 | 5.82 | 11.52 | 18.07 |
| Lipocine Inc. (LPCN)vs › | $17.07M | 11.48 | 10.71 | 12.62 | 10.43 |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.77M | 6.03 | 7.38 | 5.70 | 5.02 |
| Palatin Technologies, Inc. (PTN)vs › | $16.73M | 4.61 | 2.49 | 1.75 | 2.54 |
Quick Ratio
0.46
Excludes inventory
Current Ratio
0.46
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.46 |
| 2026-03-31 | 0.33 |
| 2025-12-31 | 0.24 |
| 2025-09-30 | 0.32 |
| 2025-06-30 | 0.31 |
| 2025-03-31 | 0.38 |
| 2024-12-31 | 0.37 |
| 2024-09-30 | 0.53 |
| 2024-06-30 | 0.69 |
| 2024-03-31 | 0.55 |
| 2023-12-31 | 0.55 |
| 2023-09-30 | 0.67 |
| 2023-06-30 | 0.69 |
| 2023-03-31 | 0.41 |
| 2022-12-31 | 0.42 |
| 2022-09-30 | 0.55 |
| 2022-06-30 | 0.75 |
| 2022-03-31 | 0.91 |
| 2021-12-31 | 1.01 |
| 2021-09-30 | 0.45 |
| 2021-06-30 | 0.69 |
| 2021-03-31 | 0.79 |
| 2020-12-31 | 1.00 |
| 2020-09-30 | 0.98 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
